有无妊娠期糖尿病孕妇的持续葡萄糖监测特征
前瞻性观察研究纳入768名孕17周前入组者,佩戴盲法Dexcom G6持续葡萄糖监测(CGM)至分娩。58例(8%)经口服葡萄糖耐量试验(OGTT)诊断妊娠期糖尿病(GDM),其CGM平均葡萄糖、血糖标准差及高血糖时间百分比均高于无GDM者,且差异最早在孕13-14周出现。
要点
- GDM孕妇平均葡萄糖109±13 vs 100±8 mg/dL(6.0±0.7 vs 5.6±0.4 mmol/L),P<0.001。
- GDM孕妇血糖标准差23±4 vs 19±3 mg/dL(1.3±0.2 vs 1.1±0.2 mmol/L),P<0.001。
- GDM孕妇63-120 mg/dL范围内时间70%±17% vs 84%±8%,P<0.001。
核心结论
- 在孕24-34周OGTT之前,最终发生GDM的孕妇相比未发生GDM者,CGM测得的葡萄糖水平更高且高血糖时间更多。
研究设计与样本
- 前瞻性观察研究,2020年6月至2021年12月从两个中心在孕17周前入组768人,全程佩戴盲法Dexcom G6 CGM。
- 主要结局为经OGTT诊断的GDM。
主要发现
- GDM组(n=58,8%)平均葡萄糖109±13 vs 无GDM组100±8 mg/dL(6.0±0.7 vs 5.6±0.4 mmol/L),P<0.001。
- GDM组血糖标准差23±4 vs 无GDM组19±3 mg/dL(1.3±0.2 vs 1.1±0.2 mmol/L),P<0.001。
- GDM组63-120 mg/dL(3.5-6.7 mmol/L)范围内时间70%±17% vs 无GDM组84%±8%,P<0.001。
- GDM组>120 mg/dL(>6.7 mmol/L)时间百分比中位数23% vs 无GDM组12%,P<0.001。
- GDM组>140 mg/dL(>7.8 mmol/L)时间百分比中位数7.4% vs 无GDM组2.7%,P<0.001。
关键数值与推荐
- GDM组>120 mg/dL(>6.7 mmol/L)时间百分比中位数在孕13-14周即高于无GDM组(32% vs 14%,P<0.001)。
- GDM组>140 mg/dL(>7.8 mmol/L)时间百分比中位数在孕13-14周即高于无GDM组(5.2% vs 2.0%,P<0.001),并持续至OGTT前整个研究期。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether continuous glucose monitoring (CGM)-derived glycemic patterns can characterize pregnancies with gestational diabetes mellitus (GDM) as diagnosed by standard oral glucose tolerance test at 24-28 weeks' gestation compared with those without GDM. RESEARCH DESIGN AND METHODS: The analysis includes 768 individuals enrolled from two sites prior to 17 weeks' gestation between June 2020 and December 2021 in a prospective observational study. Participants wore blinded Dexcom G6 CGMs throughout gestation. Main outcome of interest was a diagnosis of GDM by oral glucose tolerance test (OGTT). Glycemic levels in participants with GDM versus without GDM were characterized using CGM-measured glycemic metrics. RESULTS: Participants with GDM (n = 58 [8%]) had higher mean glucose (109 ± 13 vs. 100 ± 8 mg/dL [6.0 ± 0.7 vs. 5.6 ± 0.4 mmol/L], P < 0.001), greater glucose SD (23 ± 4 vs. 19 ± 3 mg/dL [1.3 ± 0.2 vs. 1.1 ± 0.2 mmol/L], P < 0.001), less time in range 63-120 mg/dL (3.5-6.7 mmol/L) (70% ± 17% vs. 84% ± 8%, P < 0.001), greater percent time >120 mg/dL (>6.7 mmol/L) (median 23% vs. 12%, P < 0.001), and greater percent time >140 mg/dL (>7.8 mmol/L) (median 7.4% vs. 2.7%, P < 0.001) than those without GDM throughout gestation prior to OGTT. Median percent time >120 mg/dL (>6.7 mmol/L) and time >140 mg/dL (>7.8 mmol/L) were higher as early as 13-14 weeks of gestation (32% vs. 14%, P < 0.001, and 5.2% vs. 2.0%, P < 0.001, respectively) and persisted during the entire study period prior to OGTT. CONCLUSIONS: Prior to OGTT at 24-34 weeks' gestation, pregnant individuals who develop GDM have higher CGM-measured glucose levels and more hyperglycemia compared with those who do not develop GDM.
引用
- Durnwald C, Beck RW, Li Z, et al. Continuous Glucose Monitoring Profiles in Pregnancies With and Without Gestational Diabetes Mellitus. Diabetes Care. 2024. PMID: 38701400. doi:10.2337/dc23-2149
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。